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Knowledge/attitude/practices of HPV & cervical
cancer, willingness to participate in vaccine trial
in preparation for HIV & HPV vaccine trials in Mali
D Poole1*, K Tracy2, L Levitz3, S Yekta3, E Kossow3, T Huang3, M Rochas3, K Sangare4, K Tounkara5, B Aboubacar5,
O Koita4, F Siby Diallo6, S Sow7, I Téguété8, A Dolo8, F Bougoudogo9, M Lurie1, AS De Groot10
From AIDS Vaccine 2012
Boston, MA, USA. 9-12 September 2012
Background
The GAIA Vaccine Foundation (GAIA VF) has been colla-
borating with the Malian regional DOH, local HIV clini-
cians, and scientists in Bamako to prepare a site for Phase
I-III HIV vaccine trials. We recently performed two stu-
dies to evaluate HIV and HPV knowledge and willingness
to participate (WTP) in an HIV or HPV vaccination trial.
Methods
Knowledge, Attitudes, and Practices (KAP) studies were
performed in 2008 and 2011 to assess KAP related to
HIV, HIV transmission, HIV prevention, HPV, cervical
cancer, and WTP in vaccine trials. The 2008 KAP study
examined HIV KAP and WTP (399 subjects), while the
2011 pilot study examined HPV KAP and WTP for 51
subjects in the same region of Bamako. Results from a
more extensive HPV KAP (300 participants) are pending.
Results
HIV knowledge was high: over 73% of participants in
the 2008 study were knowledgeable about modes of
HIV transmission. 78% said they would participate in an
HIV vaccine trial, 65% in a malaria vaccine trial, and
61% in a tuberculosis vaccine trial. In contrast, in 2011,
less than 1% of individuals had heard of HPV. Yet 98%
of participants were WTP in an HPV vaccine trial with
the aim of obtaining approval of the vaccine in Mali.
Conclusion
WTP in vaccine trials is high among participants in these
West African surveys. In previous African KAP and WTP
studies, WTP ranged from 20% to 77% (average 47%).
Even though participants were highly willing to partici-
pate in an HPV vaccine trial, levels of knowledge were
very low. There is a significant need for expanded public
education about the link between viruses and infection in
West Africa. This study demonstrates challenges in
implementing ethical clinical trials and highlights the
need for a significant investment in health education if
truly informed consent is to be obtained.
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